These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Underlying factors in paediatric invasive pneumococcal disease in Belgium. Izurieta P; Scherbakov M; Vetter V Lancet Infect Dis; 2021 Feb; 21(2):169-170. PubMed ID: 33515517 [No Abstract] [Full Text] [Related]
3. Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study. Desmet S; Lagrou K; Wyndham-Thomas C; Braeye T; Verhaegen J; Maes P; Fieuws S; Peetermans WE; Blumental S Lancet Infect Dis; 2021 Jan; 21(1):127-136. PubMed ID: 32702303 [TBL] [Abstract][Full Text] [Related]
4. Effect of pneumococcal conjugate vaccines on invasive pneumococcal disease - Authors' reply. de Cunto Brandileone MC; Castañeda-Orjuela C; Almeida SCG; Andrade AL Lancet Infect Dis; 2021 Apr; 21(4):453-454. PubMed ID: 33773124 [No Abstract] [Full Text] [Related]
5. Continuous surveillance of invasive pneumococcal disease is key. Knol MJ; van der Ende A Lancet Infect Dis; 2021 Jan; 21(1):13-14. PubMed ID: 32702304 [No Abstract] [Full Text] [Related]
7. Issues in pneumococcal disease and pneumococcal conjugate vaccines: highlights of the 27th meeting of ESPID, Brussels, Belgium, June 9-13, 2009. Adam D Vaccine; 2009 Nov; 27(50):7133-7. PubMed ID: 19883868 [TBL] [Abstract][Full Text] [Related]
8. Effect of pneumococcal conjugate vaccines on invasive pneumococcal disease. Camargos P; Drumond E; Nascimento-Carvalho CM Lancet Infect Dis; 2021 Apr; 21(4):453. PubMed ID: 33773123 [No Abstract] [Full Text] [Related]
9. Comparing the effect of PCV10 and PCV13 paediatric vaccination programmes - Authors' reply. Agudelo CI; Castañeda-Orjuela C; Di Fabio JL; Castañeda E Lancet Infect Dis; 2021 Feb; 21(2):171-172. PubMed ID: 33515520 [No Abstract] [Full Text] [Related]
10. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740]. Rodgers GL; Arguedas A; Cohen R; Dagan R Vaccine; 2009 Sep; 27(40):5429-30. PubMed ID: 19643215 [No Abstract] [Full Text] [Related]
12. The conjugate vaccine and invasive pneumococcal disease. Fedson DS N Engl J Med; 2003 Aug; 349(7):714-6; author reply 714-6. PubMed ID: 12917316 [No Abstract] [Full Text] [Related]
13. [Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain]. Blanco Quirós A; Giménez Sánchez F; Asensi Botet F; Bernaola Iturbe E; Martín Fde J; García Pérez J; Garcés Sánchez M; Gómez Campderá JA; Picazo JJ; Pineda Solas V; An Esp Pediatr; 2002 Oct; 57(4):287-9. PubMed ID: 12392660 [No Abstract] [Full Text] [Related]
14. Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine. Obando I; Arroyo LA; Sánchez-Tatay D; Tarragó D; Moreno D; Hausdorff WP; Brueggemann AB Clin Microbiol Infect; 2007 Mar; 13(3):347-8. PubMed ID: 17391398 [No Abstract] [Full Text] [Related]
15. 27th Annual Meeting of the European Society for Pediatric Infectious Disease. Dinleyici EC; Yargic ZA Expert Rev Vaccines; 2009 Sep; 8(9):1143-9. PubMed ID: 19722887 [TBL] [Abstract][Full Text] [Related]
16. Direct effects of pneumococcal conjugate vaccines among children in Latin America and the Caribbean. Whitney CG; Toscano CM Lancet Infect Dis; 2021 Mar; 21(3):306-308. PubMed ID: 32986995 [No Abstract] [Full Text] [Related]
17. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine. Yildirim I; Shea KM; Pelton SI Infect Dis Clin North Am; 2015 Dec; 29(4):679-97. PubMed ID: 26610421 [TBL] [Abstract][Full Text] [Related]
19. Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study. Ouldali N; Varon E; Levy C; Angoulvant F; Georges S; Ploy MC; Kempf M; Cremniter J; Cohen R; Bruhl DL; Danis K Lancet Infect Dis; 2021 Jan; 21(1):137-147. PubMed ID: 32702302 [TBL] [Abstract][Full Text] [Related]
20. Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population. Verhagen LM; Rivera-Olivero IA; Hermsen M; Sisco MC; Maes M; Del Nogal B; Bogaert D; Berbers GA; Hermans PW; de Jonge MI; de Waard JH Eur Respir J; 2016 Nov; 48(5):1492-1496. PubMed ID: 27540017 [No Abstract] [Full Text] [Related] [Next] [New Search]